Jaguar Health, Inc.
JAGXHealthcare|Biotechnology|US
$0.40
-0.00 (-0.69%)
Cash / Share
$122.17
Ownership Breakdown
93.8%
Float
2.3M
Shares Outstanding
2.2M
Float Shares
Major Holders (12)
Combined: 90.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Joshua Mailman | Individual | 9.99% | 189,617 | Sep 24, 2026 | 13D/G |
| John Fife and Fredrick Waid | Individual | 9.90% | 1,290,000 | Jan 29, 2025 | 13D/G |
| Iliad Research & Trading, L.P. | Partnership | 9.80% | 440,000 | Dec 11, 2025 | 13D/G |
| Iliad Management, LLC | Other | 9.80% | 440,000 | Dec 11, 2025 | 13D/G |
| Fife Trading, Inc. | Other | 9.80% | 440,000 | Dec 11, 2025 | 13D/G |
| John M. Fife | Individual | 9.80% | 440,000 | Dec 11, 2025 | 13D/G |
| John M Fife | Individual | 6.70% | 45,478 | May 8, 2025 | 13D/G |
| Mitchell P. Kopin | HC, IN | 4.99% | 65,002 | May 27, 2025 | 13D/G |
| Intracoastal Capital LLC | Other | 4.99% | 65,002 | May 27, 2025 | 13D/G |
| Daniel B. Asher | HC, IN | 4.99% | 65,002 | May 27, 2025 | 13D/G |
| Heights Capital Management, Inc. | Corporation | 4.60% | 164,204 | Nov 7, 2025 | 13D/G |
| CVI Investments, Inc. | Corporation | 4.60% | 164,204 | Nov 7, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 784,592 acquired · 70,205 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| MICEK JOHN | director | Dec 11, 2025 | AWARD | 7,377 | — | — | Form 4 |
| MICEK JOHN | director | Dec 11, 2025 | AWARD | 7,377 | $1.44 | $10.6K | Form 4 |
| King Steven R. | See Remarks | Dec 11, 2025 | AWARD | 11,740 | — | — | Form 4 |
| King Steven R. | See Remarks | Dec 11, 2025 | AWARD | 11,740 | $1.44 | $16.9K | Form 4 |
| CONTE LISA A | director, officer: See Remarks | Dec 11, 2025 | AWARD | 28,592 | — | — | Form 4 |
| CONTE LISA A | director, officer: See Remarks | Dec 11, 2025 | AWARD | 28,592 | $1.44 | $41.2K | Form 4 |
| Wolin Jonathan S. | See Remarks | Dec 11, 2025 | AWARD | 11,740 | — | — | Form 4 |
| Wolin Jonathan S. | See Remarks | Dec 11, 2025 | AWARD | 11,740 | $1.44 | $16.9K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Dec 11, 2025 | AWARD | 11,740 | — | — | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Dec 11, 2025 | AWARD | 11,740 | $1.44 | $16.9K | Form 4 |
| BOCHNOWSKI JAMES J | director | Dec 11, 2025 | AWARD | 6,363 | — | — | Form 4 |
| BOCHNOWSKI JAMES J | director | Dec 11, 2025 | AWARD | 6,363 | $1.44 | $9.2K | Form 4 |
| Siegel Jonathan B. | director | Dec 11, 2025 | AWARD | 7,377 | — | — | Form 4 |
| Siegel Jonathan B. | director | Dec 11, 2025 | AWARD | 7,377 | $1.44 | $10.6K | Form 4 |
| Jayasuriya Anula | director | Dec 11, 2025 | AWARD | 5,870 | — | — | Form 4 |
| Jayasuriya Anula | director | Dec 11, 2025 | AWARD | 5,870 | $1.44 | $8.5K | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Dec 11, 2025 | AWARD | 11,740 | — | — | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Dec 11, 2025 | AWARD | 11,740 | $1.44 | $16.9K | Form 4 |
| Lincoln Alternative Strategies LLC | 10 percent owner | Aug 28, 2025 | OTHER | 0 | — | — | Form 4 |
| Siegel Jonathan B. | director | Jun 24, 2025 | AWARD | 9,462 | $5.55 | $52.6K | Form 4 |
| Siegel Jonathan B. | director | Jun 24, 2025 | AWARD | 18,262 | $2.70 | $49.3K | Form 4 |
| Siegel Jonathan B. | director | Jun 24, 2025 | DISPOSED | 9,000 | $5.55 | $50.0K | Form 4 |
| MICEK JOHN | director | Jun 24, 2025 | AWARD | 9,462 | $5.55 | $52.6K | Form 4 |
| MICEK JOHN | director | Jun 24, 2025 | AWARD | 18,262 | $2.70 | $49.3K | Form 4 |
| MICEK JOHN | director | Jun 24, 2025 | DISPOSED | 9,000 | $5.55 | $50.0K | Form 4 |
| BOCHNOWSKI JAMES J | director | Jun 24, 2025 | AWARD | 28,388 | $5.55 | $157.7K | Form 4 |
| BOCHNOWSKI JAMES J | director | Jun 24, 2025 | AWARD | 54,786 | $2.70 | $147.9K | Form 4 |
| BOCHNOWSKI JAMES J | director | Jun 24, 2025 | DISPOSED | 27,002 | $5.55 | $150.0K | Form 4 |
| King Steven R. | See Remarks | Jun 24, 2025 | AWARD | 3,785 | $5.55 | $21.0K | Form 4 |
| King Steven R. | See Remarks | Jun 24, 2025 | AWARD | 7,304 | $2.70 | $19.7K | Form 4 |
| King Steven R. | See Remarks | Jun 24, 2025 | DISPOSED | 3,600 | $5.55 | $20.0K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Jun 24, 2025 | AWARD | 3,785 | $5.55 | $21.0K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Jun 24, 2025 | AWARD | 7,304 | $2.70 | $19.7K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Jun 24, 2025 | DISPOSED | 3,600 | $5.55 | $20.0K | Form 4 |
| Wolin Jonathan S. | See Remarks | Jun 24, 2025 | AWARD | 9,462 | $5.55 | $52.6K | Form 4 |
| Wolin Jonathan S. | See Remarks | Jun 24, 2025 | AWARD | 18,262 | $2.70 | $49.3K | Form 4 |
| Wolin Jonathan S. | See Remarks | Jun 24, 2025 | DISPOSED | 9,000 | $5.55 | $50.0K | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Jun 24, 2025 | AWARD | 9,462 | $5.55 | $52.6K | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Jun 24, 2025 | AWARD | 18,262 | $2.70 | $49.3K | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Jun 24, 2025 | DISPOSED | 9,000 | $5.55 | $50.0K | Form 4 |
| King Steven R. | See Remarks | May 17, 2025 | OPTION EX. | 1 | — | — | Form 4 |
| King Steven R. | See Remarks | May 17, 2025 | OPTION EX. | 1 | — | — | Form 4 |
| CONTE LISA A | director, officer: CEO and President | May 17, 2025 | OPTION EX. | 2 | — | — | Form 4 |
| CONTE LISA A | director, officer: CEO and President | May 17, 2025 | OPTION EX. | 2 | — | — | Form 4 |
| MICEK JOHN | director | Mar 31, 2025 | BUY | 9,000 | $5.43 | $48.9K | Form 4 |
| MICEK JOHN | director | Mar 31, 2025 | BUY | 9,000 | $5.55 | $50.0K | Form 4 |
| King Steven R. | See Remarks | Mar 31, 2025 | BUY | 3,600 | $5.55 | $20.0K | Form 4 |
| King Steven R. | See Remarks | Mar 31, 2025 | BUY | 3,600 | $5.43 | $19.5K | Form 4 |
| Siegel Jonathan B. | director | Mar 31, 2025 | BUY | 9,000 | $5.55 | $50.0K | Form 4 |
| Siegel Jonathan B. | director | Mar 31, 2025 | BUY | 9,000 | $5.43 | $48.9K | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Mar 31, 2025 | BUY | 9,000 | $5.43 | $48.9K | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Mar 31, 2025 | BUY | 9,000 | $5.55 | $50.0K | Form 4 |
| Wolin Jonathan S. | See Remarks | Mar 31, 2025 | BUY | 9,000 | $5.55 | $50.0K | Form 4 |
| Wolin Jonathan S. | See Remarks | Mar 31, 2025 | BUY | 9,000 | $5.43 | $48.9K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Mar 31, 2025 | BUY | 3,600 | $5.55 | $20.0K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Mar 31, 2025 | BUY | 3,600 | $5.43 | $19.5K | Form 4 |
| BOCHNOWSKI JAMES J | director | Mar 31, 2025 | BUY | 27,002 | $5.55 | $150.0K | Form 4 |
| BOCHNOWSKI JAMES J | director | Mar 31, 2025 | BUY | 27,002 | $5.43 | $146.6K | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Mar 31, 2025 | BUY | 5,400 | $5.43 | $29.3K | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Mar 31, 2025 | BUY | 5,400 | $5.55 | $30.0K | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Oct 8, 2024 | AWARD | 34,240 | $1.29 | $44.2K | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Oct 8, 2024 | AWARD | 4,280 | — | — | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Oct 8, 2024 | AWARD | 39,376 | $1.29 | $50.8K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Oct 8, 2024 | AWARD | 4,922 | — | — | Form 4 |
| Wolin Jonathan S. | See Remarks | Oct 8, 2024 | AWARD | 39,376 | $1.29 | $50.8K | Form 4 |
| Wolin Jonathan S. | See Remarks | Oct 8, 2024 | AWARD | 4,922 | — | — | Form 4 |
| CONTE LISA A | director, officer: See Remarks | Oct 8, 2024 | AWARD | 132,020 | $1.29 | $170.3K | Form 4 |
| CONTE LISA A | director, officer: See Remarks | Oct 8, 2024 | AWARD | 16,503 | — | — | Form 4 |
| MICEK JOHN | director | Oct 8, 2024 | AWARD | 26,500 | $1.29 | $34.2K | Form 4 |
| BOCHNOWSKI JAMES J | director | Oct 8, 2024 | AWARD | 23,200 | $1.29 | $29.9K | Form 4 |
| Jayasuriya Anula | director | Oct 8, 2024 | AWARD | 21,000 | $1.29 | $27.1K | Form 4 |
| King Steven R. | See Remarks | Oct 8, 2024 | AWARD | 39,376 | $1.29 | $50.8K | Form 4 |
| King Steven R. | See Remarks | Oct 8, 2024 | AWARD | 4,922 | — | — | Form 4 |
| Siegel Jonathan B. | director | Oct 8, 2024 | AWARD | 26,500 | $1.29 | $34.2K | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | May 17, 2024 | OPTION EX. | 871 | — | — | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | May 17, 2024 | OPTION EX. | 871 | — | — | Form 4 |
| Wolin Jonathan S. | Chief of Staff, CCO & GC | May 17, 2024 | OPTION EX. | 871 | — | — | Form 4 |
| Wolin Jonathan S. | Chief of Staff, CCO & GC | May 17, 2024 | OPTION EX. | 871 | — | — | Form 4 |
| Lizak Carol R. | Chief Financial Officer | May 17, 2024 | OPTION EX. | 431 | — | — | Form 4 |
| Lizak Carol R. | Chief Financial Officer | May 17, 2024 | OPTION EX. | 431 | — | — | Form 4 |
| King Steven R. | See Remarks | May 17, 2024 | OPTION EX. | 612 | — | — | Form 4 |
| King Steven R. | See Remarks | May 17, 2024 | OPTION EX. | 612 | — | — | Form 4 |
| CONTE LISA A | director, officer: CEO and President | May 17, 2024 | OPTION EX. | 2,695 | — | — | Form 4 |
| CONTE LISA A | director, officer: CEO and President | May 17, 2024 | OPTION EX. | 2,695 | — | — | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Apr 5, 2024 | OPTION EX. | 134 | — | — | Form 4 |
| Chaturvedi Pravin R | Chief Scientific Officer | Apr 5, 2024 | AWARD | 134 | — | — | Form 4 |
| Wolin Jonathan S. | Chief of Staff, CCO & GC | Apr 5, 2024 | OPTION EX. | 89 | — | — | Form 4 |
| Wolin Jonathan S. | Chief of Staff, CCO & GC | Apr 5, 2024 | AWARD | 89 | — | — | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Apr 5, 2024 | OPTION EX. | 60 | — | — | Form 4 |
| Lizak Carol R. | Chief Financial Officer | Apr 5, 2024 | AWARD | 60 | — | — | Form 4 |
| King Steven R. | See Remarks | Apr 5, 2024 | OPTION EX. | 178 | — | — | Form 4 |
| King Steven R. | See Remarks | Apr 5, 2024 | AWARD | 178 | — | — | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Apr 5, 2024 | OPTION EX. | 600 | — | — | Form 4 |
| CONTE LISA A | director, officer: CEO and President | Apr 5, 2024 | AWARD | 600 | — | — | Form 4 |
| Jayasuriya Anula | director | Aug 14, 2023 | AWARD | 68,568 | — | — | Form 4 |
| Jayasuriya Anula | director | Jul 1, 2023 | AWARD | 1,718 | — | — | Form 4 |
| Jayasuriya Anula | director | Jul 1, 2023 | AWARD | 1,718 | — | — | Form 4 |
| Siegel Jonathan B. | director | Aug 14, 2023 | AWARD | 68,568 | — | — | Form 4 |
| MICEK JOHN | director | Aug 14, 2023 | AWARD | 68,568 | — | — | Form 4 |
| BOCHNOWSKI JAMES J | director | Aug 14, 2023 | AWARD | 76,613 | — | — | Form 4 |